Leap Therapeutics Statistics
Total Valuation
LPTX has a market cap or net worth of $79.21 million. The enterprise value is $23.52 million.
| Market Cap | 79.21M |
| Enterprise Value | 23.52M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LPTX has 38.26 million shares outstanding. The number of shares has increased by 108.85% in one year.
| Shares Outstanding | 38.26M |
| Shares Change (YoY) | +108.85% |
| Shares Change (QoQ) | +32.13% |
| Owned by Insiders (%) | 14.13% |
| Owned by Institutions (%) | 34.21% |
| Float | 26.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.38 |
| Quick Ratio | 5.44 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -81.00% and return on invested capital (ROIC) is -124.44%.
| Return on Equity (ROE) | -81.00% |
| Return on Assets (ROA) | -68.90% |
| Return on Capital (ROIC) | -124.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$988,352 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.46% in the last 52 weeks. The beta is 0.32, so LPTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -31.46% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 2.56 |
| Relative Strength Index (RSI) | 48.40 |
| Average Volume (20 Days) | 137,742 |
Short Selling Information
The latest short interest is 1.06 million, so 2.77% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short Previous Month | 1.24M |
| Short % of Shares Out | 2.77% |
| Short % of Float | 3.99% |
| Short Ratio (days to cover) | 6.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -59.14M |
| Pretax Income | -53.37M |
| Net Income | -53.37M |
| EBITDA | -53.36M |
| EBIT | -53.37M |
| Earnings Per Share (EPS) | -$2.13 |
Balance Sheet
The company has $55.84 million in cash and $154,000 in debt, giving a net cash position of $55.68 million or $1.46 per share.
| Cash & Cash Equivalents | 55.84M |
| Total Debt | 154,000 |
| Net Cash | 55.68M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 47.37M |
| Book Value Per Share | 1.24 |
| Working Capital | 45.75M |
Cash Flow
| Operating Cash Flow | -46.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -46.57M |
| FCF Per Share | -$1.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LPTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -108.85% |
| Shareholder Yield | -108.85% |
| Earnings Yield | -67.38% |
| FCF Yield | -58.79% |
Analyst Forecast
The average price target for LPTX is $10.40, which is 402.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.40 |
| Price Target Difference | 402.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -24.20% |
Stock Splits
The last stock split was on June 21, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 21, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |